Company: LGN
Filing Date: 2025-07-15
Form Type: DRS/A
Source: 0000950123-25-006399
Chunk: 176

Company: Legence Corp.
Filing Date: 2025-07-15
Form: DRS/A
Chunk 176
---
 and transportation requirements.

Project-Specific Regulations. From time to time, we may take on
projects that require us to comply with project-specific rules or requirements, including regulations relating to the handling, treatment, storage and disposal of hazardous materials, regulations relating to aviation activities, limitations on the
availability or sourcing of materials or components for our clients’ projects, public health regulations, or regulations regarding the engagement of suppliers and subcontractors that meet diverse-ownership or disadvantaged-business
requirements. For example, our projects involving healthcare facilities have in the past required any personnel assigned to those projects to receive certain vaccines. Project-specific requirements may cause delays in initiating or completing such
projects as we seek to hire qualified personnel or acquire appropriate materials. Further, our relative unfamiliarity with certain regimes may increase our risk of noncompliance.

Failure to comply with applicable regulations, however, could cause delays, subject us to lawsuits, substantial fines, revocation of our
operating licenses, and/or give rise to termination or cancellation rights under our contracts or disqualify us from future bidding opportunities, among other things. Further, we incur substantial costs in complying with, and monitoring our
compliance with applicable rules and regulations. See the sections titled “Risk Factors—Risks Related to Regulations” and “Risk Factors—Risks Related to the Environment, Health and Safety” for additional information.

Legal Proceedings

We are party to
various legal proceedings and claims in the ordinary course of our business. We believe these matters will not have a material adverse effect on our business, financial condition or results of operations. See Note 17 of our Consolidated Financial
Statements for additional information about these legal proceedings.

123

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 MANAGEMENT Directors and Executive Officers The following table sets forth the names, ages and titles of our directors, director nominee and executive officers:

| Name                    |     | Age |     | Title                                |
| Jeffrey Sprau           |     |  60 |     | Chief Executive Officer and Director |
| Stephen Butz            |     |  54 |     | Chief Financial Officer              |
| Gregory Barnes          |     |  46 |     | Chief Human Resources Officer        |
| Bryce Seki              |     |  48 |     | General Counsel                      |
| Bilal Khan              |     |  44 |     | Director                             |
| Robert Mitchell Nimocks |     |  36 |     | Director